Clinical Trial Update: A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating Macupatide and Eloralintide, alone or in combination, in adults with obesity/overweight and type 2 diabetes, and the trial is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Eloralintide (LY3841136)
• Macupatide

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 2 | Status: RECRUITING